Market Research Logo

Markets for Blood Testing and Typing

The Market for Blood Testing and Typing

This Kalorama Information report, Blood Testing and Typing Post-Zika details sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for 2011 to 2016 and forecasts are provided through 2021 and 2026. Historical information was gathered from a wide variety of published sources including company reports, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants’ point of view and assess trends.

Excluded from this report are blood testing products used in biopharmaceutical processing/manufacturing/research, and veterinary tests. Also excluded are blood products for transfusion such as red blood cells (RBCs), immunoglobulin products, synthetic blood/albumin, etc. as well as blood testing services/laboratories.

The total global market for blood testing and typing products includes products and devices used in blood banking/donations as well as products used otherwise. This can also be thought of as testing and typing on pooled blood donations (blood bank) versus individual blood samples. In both of these segments, the following products are used:

  • Pathogen screening by immunoassay;
  • Pathogen screening by NAT;
  • Blood typing and grouping;
The global blood industry represents a diverse assortment of companies, groups and organizations that provide for the safe collection, testing, storage and delivery of human blood and blood products for transfusion. These blood transfusions are of critical importance to those with both acute and chronic medical conditions in which blood is depleted or non-functioning, since more than 9 million Americans and Europeans would die each year without transfusions.

The following sections provide highlights of the blood industry’s ongoing technological development and a background on the physiological aspects of human blood, which will form the basis for understanding the blood testing and typing industries profiled in detail in this report’s later chapters.This Kalorama Information report, Blood Testing and Typing Post-Zika details sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for 2011 to 2016 and forecasts are provided through 2021 and 2026. Historical information was gathered from a wide variety of published sources including company reports, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants’ point of view and assess trends.

Excluded from this report are blood testing products used in biopharmaceutical processing/manufacturing/research, and veterinary tests. Also excluded are blood products for transfusion such as red blood cells (RBCs), immunoglobulin products, synthetic blood/albumin, etc. as well as blood testing services/laboratories.

The total global market for blood testing and typing products includes products and devices used in blood banking/donations as well as products used otherwise. This can also be thought of as testing and typing on pooled blood donations (blood bank) versus individual blood samples. In both of these segments, the following products are used:
  • Pathogen screening by immunoassay;
  • Pathogen screening by NAT;
  • Blood typing and grouping;
The global blood industry represents a diverse assortment of companies, groups and organizations that provide for the safe collection, testing, storage and delivery of human blood and blood products for transfusion. These blood transfusions are of critical importance to those with both acute and chronic medical conditions in which blood is depleted or non-functioning, since more than 9 million Americans and Europeans would die each year without transfusions.

The following sections provide highlights of the blood industry’s ongoing technological development and a background on the physiological aspects of human blood, which will form the basis for understanding the blood testing and typing industries profiled in detail in this report’s later chapters.


  • Executive Summary
    • The Global Blood Testing and Typing Industry Post Zika
    • Scope and Methodology
    • The Total Blood Testing and Typing Products Market
    • Overview
      • The Global Blood Industry
      • History of the Blood Industry
        • Table History of Blood Testing Year
      • United States
      • Europe
      • Asia
      • Africa
    • Zika Virus
  • Current Blood Industry Issues
    • Effects of the Economy
    • Changes from Health Care Reform
    • Demographic Shifts
      • Table U.S. Expectation of Life at Birth, by Sex and Race, 2015
    • Basics - Blood and its Components
      • Red Blood Cells (Erythrocytes)
      • RBC Shelf Life
      • White Blood Cells (Leukocytes)
      • Platelets
      • Plasma
        • Table Composition of Blood Plasma
      • Immunoglobulin Products
      • Blood Transfusions
      • Diseases Contracted from Blood Transfusions and Related Identification Testing
      • Donor Deferral and Special Populations of Donors
      • Transfusion-Associated Risks
      • Questions about the Necessity of Transfusion
      • Biovigilence
  • The Blood Collection System: Blood Donation, Processing and Use
    • Blood Collection
    • Organizations Collecting Blood
      • Not-For-Profit Blood Collection
      • Red Cross
      • Community Blood Banks
      • Hospitals
      • Other Blood Collection Sites
      • For-Profit Blood Collection
      • National Donor Deferral Registry
      • Donor Donation Demographics
      • Donor Recruitment
      • Blood Screening and Evaluation
      • Improving Donor Screening
    • Methods for Collecting Blood from Donors
      • Manual Blood Collection
      • Automated Blood Collection
        • Table Worldwide Annual Blood Collection by Component
      • Plasmapheresis
      • Plateletpheresis
      • Leukopheresis
      • Red Blood Cell Apheresis
      • Cord Blood Collection
      • Plasma Collection
      • Plasma Fractionators
      • Distributors/Brokers
      • Blood Storage
      • Blood Freshness
      • Blood Processing
      • Cohn Fractionation
        • Table Results of Cohn Fractionation Method
      • Newer Fractionation Methods
        • Table Plasma Proteins of Therapeutic Interest
      • Advanced Fractionation Methods
      • Cascade Plasma Fractionation
      • Automated Fractionation
      • Types of Blood Transfusions
      • Whole Blood
      • Packed Red Blood Cells
      • Platelets
      • Leukocytes
      • Fresh Frozen Plasma (FFP)
      • Cryoprecipitate
      • Immune Serum Globulin/IMIG/IGIV
      • Factor VIII
      • Factor IX and Factor IX Complex
      • Factor VIIa
      • C1 Inhibitor
      • Fibrin/Thrombin
      • Therapeutic Apheresis
      • Blood Management Issues
      • Increasing Repeat Donation Rates
      • Increasing Voluntary Donation
      • Other Safety Precautions
  • Blood Typing and Testing Segments
    • Blood Typing and Testing for Diseases
    • Blood Typing
      • Table Basic Blood Types
      • Table Blood Transfusion Compatibility
    • Methods of Blood Typing
    • Manual Blood Typing Methods
    • Automated Blood Typing and Screening Methods
    • Molecular methods
    • Reducing Blood Typing Errors
    • Blood Testing
    • Nucleic Acid Amplification Testing (NAT)
    • CBER Licensed NAT Screening Tests
    • Infectious Disease
    • West Nile Virus
    • Oncology
    • Inherited Disease
    • Other
    • Polymerase Chain Reaction (PCR) Amplification
    • CBER Licensed PCR Screening Tests
      • Table PCR-Based Screening Tests Licensed by CBER
    • DNA Sequencing/Genetic Testing
    • Immunoassay
    • Infectious Diseases
    • Chagas Disease
    • Cardiac Markers
    • Tumor Markers
    • Diabetes
    • Autoimmune Diseases
    • Other
    • Enzyme-Linked Immunosorbent Assay
    • Basic ELISA
      • Table Comparison of Direct and Indirect ELISA Tests
    • Competitive ELISA
    • Reverse Sandwich Method
    • Reverse Sandwich Inhibition Method
    • MAC-ELISA
    • Zika MAC-ELISA
    • Plaque Reduction Neutralization Test (PRNT)
    • Tests for Infectious Disease
    • Improving Viral Screening
    • Costs and Other Barriers
    • Testing Before Transfusion
    • Coombs Test
    • Crossmatch
    • Major Crossmatch
    • Minor Crossmatch
    • Antibody Screen
    • Efforts to Create a Virus-Free Blood Supply
    • Plasma Treatment
      • Table Risk of Contamination
      • Table Viral Inactivation by Procedure Procedure
    • Platelet Treatments
    • Testing for Contamination
    • Pathogen Reduction
    • Preventing Bacterial Infections
    • Red Blood Cell Treatments
      • Table Viral Inactivation Methods for Viruses Found in Red Blood Cells
  • Blood Testing and Typing Product Markets
    • The Total Blood Testing and Typing Products Market
      • Table Global Blood Testing and Typing Market Forecast by Segment, 2016
      • Market Growth for Testing and Typing
        • Table Global Blood Testing and Typing Market Growth by Segment: 2011-2026
      • Blood Testing and Typing Market by Type (Instrument/Consumable)
        • Table Breakout of Instrument vs. Consumable Revenue, by Percent of Market
    • Blood Testing Market
      • Blood Testing Market: Immunoassay versus Nucleic Acid Testing
      • Blood Testing Market by Geography
        • Table Geographical Distribution for Immunoassay versus Nucleic Acid Testing Products in Blood Banks: 2016
      • Immunoassay Market by Disease
        • Table Global Blood Banking and Plasmapheresis Testing Market for Immunoassays: 2011-2026 by Disease Tested For (HIV, HCV, HBV, Syph, Others)
      • NAT Blood Testing Market by Disease
        • Table Global Blood Banking and Plasmapheresis Testing Market for NAT: 2011-2026
    • Blood Typing & Grouping Market and Forecast
      • Table Total Global Market for Blood Typing & Grouping Products in Blood Banks: 2011-2026
      • Blood Typing and Grouping by Geography
        • Table Geographical Distribution for Blood Typing & Grouping Products in Blood Banks: 2016
    • Competitive Analysis
      • Market Share - Blood Bank Testing
        • Table Blood Bank Testing Market Share Company Share
      • Nucleic Acid Tests
      • Blood Typing and Grouping Competitive Analysis
        • Table Blood Typing Market Share
  • Company Profiles
    • AABB
    • Abbott Laboratories
    • Akers Biosciences
    • America's Blood Centers
    • American Red Cross
    • Beckman Coulter
    • Becton Dickinson & Co.
    • Biomerieux, Inc.
    • Bio-Rad Laboratories
    • DiaSorin
    • Grifols Biologicals, Inc.
    • Hologic
    • Haemonetics
    • Immucor
    • Micronics
    • Ortho Clinical Diagnostics
    • Qiagen Diagnostics
    • Reliance Life Sciences
    • Roche
    • Siemens
    • TerumoBCT

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report